122 related articles for article (PubMed ID: 24470460)
41. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients.
Vink EE; Blankestijn PJ
Hypertension; 2013 Feb; 61(2):e8. PubMed ID: 23213193
[No Abstract] [Full Text] [Related]
42. Blood pressure lowering effect of renal sympathetic denervation or placebo? - building expectations for Symplicity-HTN 3.
Kjeldsen SE; Narkiewicz K; Oparil S; Hedner T
Blood Press; 2013 Oct; 22(5):279-81. PubMed ID: 24059787
[No Abstract] [Full Text] [Related]
43. Renal denervation in hypertension: simplicity, or complexity?
Lantelme P; Courand PY; Bricca G
Arch Cardiovasc Dis; 2014; 107(8-9):421-3. PubMed ID: 25128935
[No Abstract] [Full Text] [Related]
44. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
Symplicity HTN-1 Investigators
Hypertension; 2011 May; 57(5):911-7. PubMed ID: 21403086
[TBL] [Abstract][Full Text] [Related]
45. Health-related quality of life after renal denervation in patients with treatment-resistant hypertension.
Lambert GW; Hering D; Esler MD; Marusic P; Lambert EA; Tanamas SK; Shaw J; Krum H; Dixon JB; Barton DA; Schlaich MP
Hypertension; 2012 Dec; 60(6):1479-84. PubMed ID: 23071129
[TBL] [Abstract][Full Text] [Related]
46. Adhesion molecules, activin and inhibin--candidates for the biochemical prediction of hypertensive diseases in pregnancy?
Hanisch CG; Pfeiffer KA; Schlebusch H; Schmolling J
Arch Gynecol Obstet; 2004 Sep; 270(2):110-5. PubMed ID: 12898146
[TBL] [Abstract][Full Text] [Related]
47. Lack of blood pressure-lowering effect of renal denervation in a drug-naïve patient with pronounced arterial stiffening.
von Arx R; Rexhaj E; Allemann Y; Moschovitis A; Windecker S; Meier B; Scherrer U; Rimoldi SF
Am J Med; 2014 Sep; 127(9):e3-4. PubMed ID: 24858061
[No Abstract] [Full Text] [Related]
48. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series.
Mahfoud F; Böhm M; Rump LC; Vonend O; Schmieder RE; Kintscher U
Hypertension; 2013 Feb; 61(2):e17. PubMed ID: 23248153
[No Abstract] [Full Text] [Related]
49. [Is the French procedure of renal denervation effective?].
Füeßl HS
MMW Fortschr Med; 2015 Jun; 157(11):33. PubMed ID: 26049342
[No Abstract] [Full Text] [Related]
50. Resistant Hypertension: Mineralocorticoid Receptor Antagonist or Renal Denervation?
Carey RM
Hypertension; 2016 Feb; 67(2):278-80. PubMed ID: 26693820
[No Abstract] [Full Text] [Related]
51. Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension.
Hering D; Marusic P; Walton AS; Duval J; Lee R; Sata Y; Krum H; Lambert E; Peter K; Head G; Lambert G; Esler MD; Schlaich MP
Int J Cardiol; 2016 Jan; 202():388-93. PubMed ID: 26432488
[TBL] [Abstract][Full Text] [Related]
52. Renal denervation: the Irish experience.
Kyvelou SM; Sharif F; Tuohy S; Jatoi NA; Vlachopoulos C; Stefanadis C
Hellenic J Cardiol; 2013; 54(6):486-7. PubMed ID: 24305589
[No Abstract] [Full Text] [Related]
53. Late renal artery stenosis after renal denervation: is it the tip of the iceberg?
Versaci F; Trivisonno A; Olivieri C; Caranci F; Brunese L; Prati F
Int J Cardiol; 2014 Apr; 172(3):e507-8. PubMed ID: 24485602
[No Abstract] [Full Text] [Related]
54. Effects of renal sympathetic denervation on exercise blood pressure, heart rate, and capacity in patients with resistant hypertension.
Ewen S; Mahfoud F; Linz D; Pöss J; Cremers B; Kindermann I; Laufs U; Ukena C; Böhm M
Hypertension; 2014 Apr; 63(4):839-45. PubMed ID: 24420550
[TBL] [Abstract][Full Text] [Related]
55. Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension.
Ukena C; Mahfoud F; Kindermann I; Barth C; Lenski M; Kindermann M; Brandt MC; Hoppe UC; Krum H; Esler M; Sobotka PA; Böhm M
J Am Coll Cardiol; 2011 Sep; 58(11):1176-82. PubMed ID: 21884958
[TBL] [Abstract][Full Text] [Related]
56. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
Hering D; Marusic P; Walton AS; Lambert EA; Krum H; Narkiewicz K; Lambert GW; Esler MD; Schlaich MP
Hypertension; 2014 Jul; 64(1):118-24. PubMed ID: 24732891
[TBL] [Abstract][Full Text] [Related]
57. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578
[TBL] [Abstract][Full Text] [Related]
58. Role of renal sympathetic denervation in a refractory arterial hypertension patient.
Martínez-Esteban MD; Aranda-Lara P; Muñoz J; Toledo-Rojas R; Sola-Moyano E; Torres-Rueda Á; Hernández-Marrero D
Nefrologia; 2012; 32(5):670-3. PubMed ID: 23013955
[TBL] [Abstract][Full Text] [Related]
59. Intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 in children. Do they play a role in the progression of atherosclerosis?
Fotis L; Giannakopoulos D; Stamogiannou L; Xatzipsalti M
Hormones (Athens); 2012; 11(2):140-6. PubMed ID: 22801559
[No Abstract] [Full Text] [Related]
60. Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence.
Hiremath S; Froeschl M; Ruzicka M
Curr Opin Cardiol; 2014 Jul; 29(4):336-43. PubMed ID: 24859619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
